UNH
Unitedhealth Group Inc Health Care Hospital & Medical Service Plans S&P 500Dow 30Russell 3000
$406.97Close
$368.7BMarket cap
$257.55 – $433.6852-week range
Mid-januaryNext report · estimated
Highlights
Strengths
- Earnings growing EPS +62% year on year, faster than the quarter before (+61 pts)
Cautions
- Trend not confirmed 7 of 8 conditions · RS under 70
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
6%
1wk
down 2.7%
price change
1mo
up 10.9%
price change
12-month return
up 20%
market up 11% ·
its own up 6%
F-score
7 / 9
Strong
Altman Z″
1.41
Moderate risk
P/E
30.6×
price / earnings
PEG
—
P/E / EPS growth
P/B
3.7×
price / book
Earnings yield
up 4.6%
EBIT / enterprise value
Cheaper than
56%
of the market · around average
Revenue growth
up 12%
year on year
EPS growth
up 62%
latest quarter · +61 pts
Sales growth
0%
latest quarter · -2 pts
ROE
up 12%
return on equity
Free cash margin
up 4%
$16.1B FCF
D/E
0.72
long-term debt / equity
Net debt / EBITDA
2.1×
Interest cover
4.7×EBIT / interest
Piotroski tests
- profitability slipped from last year
- short-term liquidity weakened
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- no new shares issued
- gross margin widened
- assets working harder
Trade setup
ATR%
2.7%
$10.95 a day · 2×ATR $385.07
RS
69 / 99
vs the universe
Trend
7 / 8
RS under 70
Relative volume
0.8×
vs 50-day average
Up/down volume
0.84
50 sessions
Implied move
—
no scheduled report
Trend template · 7 of 8
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Oct 13, 2026
Results reaction
Oct 13, 2026+6% vs market2 sessions after results
Options
$25.0M31.7% IV · activity
Financials
- Gross 89%
- Net 3%
- Free cash 4%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $257.1B | $287.6B | $324.2B | $371.6B | $400.3B | $447.6B |
| Gross margin | 88% | 89% | 90% | 90% | 88% | 89% |
| Operating income | $22.4B | $24.0B | $28.4B | $32.4B | $32.3B | $19.0B |
| Net income | $15.4B | $17.3B | $20.1B | $22.4B | $14.4B | $12.1B |
| Net margin | 6% | 6% | 6% | 6% | 4% | 3% |
| Earnings per share | $16.03 | $18.08 | $21.18 | $23.86 | $15.51 | $13.23 |
| Free cash flow | $20.1B | $19.9B | $23.4B | $25.7B | $20.7B | $16.1B |
| Free cash margin | 8% | 7% | 7% | 7% | 5% | 4% |
| Cash | $16.9B | $21.4B | $23.4B | $25.4B | $25.3B | $24.4B |
| Long-term debt | $38.6B | $42.4B | $54.5B | $58.3B | $72.4B | $72.3B |
| Shareholders' equity | $68.3B | $75.0B | $81.5B | $94.4B | $98.3B | $100.1B |
| Shares outstanding | 946m | 941m | 934m | 924m | 915m | 906m |
What options price now
- Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
- $378 – $434 ±6.9% by Nov 27, 2026
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- Bigger 31.7% priced · 28.2% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- About the same
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: costs more
Positioning
- Premium traded
- $25.0M calls $13.6M · puts $11.4M · latest session
- 0.84× +0.59 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls -35.98k · puts -21.05k past week
For options traders: ATM IV 31.7% (+4.0% 1w) · 1m ÷ 3m IV 1.01 · 25Δ skew 3.4 pts · Net GEX $92.4M
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 10, 2026 | Quarterly ↗ | Jun 30, 2026 | 41d |
| May 5, 2026 | Quarterly ↗ | Mar 31, 2026 | 35d |
| Mar 2, 2026 | Annual ↗ | Dec 31, 2025 | 61d |
| Oct 28, 2025 | Quarterly ↗ | Sep 30, 2025 | 28d |
| Aug 11, 2025 | Quarterly ↗ | Jun 30, 2025 | 42d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Nov 4, 2024 | Quarterly ↗ | Sep 30, 2024 | 35d |
| Aug 9, 2024 | Quarterly ↗ | Jun 30, 2024 | 40d |
| May 9, 2024 | Quarterly ↗ | Mar 31, 2024 | 39d |
| Feb 28, 2024 | Annual ↗ | Dec 31, 2023 | 59d |
| Nov 6, 2023 | Quarterly ↗ | Sep 30, 2023 | 37d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 13, 2026 | Results ↗ |
| Sep 8, 2026 | Regulation FD ↗ |
| Jul 16, 2026 | Results ↗ |
| Jun 5, 2026 | Shareholder vote ↗ |
| May 11, 2026 | Regulation FD ↗ |
| Apr 21, 2026 | Results ↗ |
| Mar 9, 2026 | Regulation FD ↗ |
| Mar 2, 2026 | Director or officer change ↗ |
| Feb 25, 2026 | Director or officer change ↗ |
| Jan 27, 2026 | Results ↗ |
| Jan 12, 2026 | Regulation FD ↗ |
| Nov 21, 2025 | Director or officer change ↗ |